0001225208-22-001509.txt : 20220204
0001225208-22-001509.hdr.sgml : 20220204
20220204164301
ACCESSION NUMBER: 0001225208-22-001509
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POLK MICHAEL B
CENTRAL INDEX KEY: 0001192505
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00644
FILM NUMBER: 22594048
MAIL ADDRESS:
STREET 1: 100 DEFOREST AVE
CITY: EAST HANOVER
STATE: NJ
ZIP: 07936
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO
CENTRAL INDEX KEY: 0000021665
STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
IRS NUMBER: 131815595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 2123102000
MAIL ADDRESS:
STREET 1: 300 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
X0306
4
2022-02-02
0000021665
COLGATE PALMOLIVE CO
CL
0001192505
POLK MICHAEL B
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
NEW YORK
NY
10022
1
Common Stock
2022-02-02
4
M
0
5389.0000
71.7600
A
25803.0000
D
Common Stock
2022-02-02
4
S
0
4681.0000
82.7414
D
21122.0000
D
Stock Option (Right to Buy)
71.7600
2022-02-02
4
M
0
5389.0000
0.0000
D
2022-05-09
Common Stock
5389.0000
0.0000
D
Exercise of stock options awarded under the issuer's incentive compensation plan.
Sale of shares with proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.
Weighted average price, as these shares were sold in multiple transactions at prices ranging from $82.7401 to $82.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Option became exercisable in one-third increments beginning on the first anniversary of the May 9, 2016 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact
2022-02-04